OM1 Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
119
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$85M
- Investors
-
10
OM1 General Information
Description
Developer of an outcome management platform designed to provide measurement, comparison and prediction of treatment outcomes. The company's platform gathers, synthesizes, enriches and leverages clinical data to give AI-driven insights and predictions that can improve clinical, financial and operational management, enabling healthcare organizations to analyze and use outcomes data in a clinically meaningful and precise way.
Contact Information
Website
www.om1.comCorporate Office
- 31 Street James Avenue
- Suite Number 1010
- Boston, MA 02116
- United States
Corporate Office
- 31 Street James Avenue
- Suite Number 1010
- Boston, MA 02116
- United States
OM1 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 16-Jul-2021 | $85M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series C) | 18-Dec-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 22-May-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 06-Apr-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 25-Sep-2015 | $4M | $5.25M | Completed | Startup | |
| 1. Seed Round | 01-Jan-2015 | $1.25M | $1.25M | Completed | Startup |
OM1 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A-1 | ||||||||
| Series A | 6,762,500 | $0.000100 | $0.13 | $0.59 | $0.59 | 1x | $0.59 | 7.04% |
| Seed | 3,125,000 | $0.000100 | $0.4 | $0.4 | 1x | $0.4 | 3.25% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
OM1 Comparisons
Industry
Financing
Details
OM1 Competitors (17)
One of OM1’s 17 competitors is MedeAnalytics, a Private Equity-Backed company based in Richardson, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MedeAnalytics | Private Equity-Backed | Richardson, TX | ||||
| Innovaccer | Venture Capital-Backed | San Francisco, CA | ||||
| FIGmd | Private Equity-Backed | Rockford, IL | ||||
| NantHealth | Formerly VC-backed | Lewisville, TX | ||||
| Clinical Ink | Private Equity-Backed | Winston-Salem, NC |
OM1 Patents
OM1 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11862346-B1 | Identification of patient sub-cohorts and corresponding quantitative definitions of subtypes as a classification system for medical conditions | Active | 22-Dec-2018 | ||
| US-12224072-B2 | Identification of patient sub-cohorts and corresponding quantitative definitions of subtypes as a classification system for medical conditions | Active | 22-Dec-2018 | ||
| US-20240096500-A1 | Identification of patient sub-cohorts and corresponding quantitative definitions of subtypes as a classification system for medical conditions | Inactive | 22-Dec-2018 | ||
| US-20240153647-A1 | Identification of patient sub-cohorts and corresponding quantitative definitions of subtypes as a classification system for medical conditions | Active | 22-Dec-2018 | ||
| US-20250191782-A1 | Identification of patient sub-cohorts and corresponding quantitative definitions of subtypes as a classification system for medical conditions | Pending | 22-Dec-2018 | G16H50/70 |
OM1 Signals
OM1 Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 7wire Ventures | Venture Capital | Minority | ||
| Breyer Capital | Venture Capital | Minority | ||
| D1 Capital Partners | Hedge Fund | Minority | ||
| Kaiser Permanente | Corporation | Minority | ||
| Koa Labs | Venture Capital | Minority |
OM1 FAQs
-
When was OM1 founded?
OM1 was founded in 2015.
-
Where is OM1 headquartered?
OM1 is headquartered in Boston, MA.
-
What is the size of OM1?
OM1 has 119 total employees.
-
What industry is OM1 in?
OM1’s primary industry is Outcome Management (Healthcare).
-
Is OM1 a private or public company?
OM1 is a Private company.
-
What is the current valuation of OM1?
The current valuation of OM1 is .
-
What is OM1’s current revenue?
The current revenue for OM1 is .
-
How much funding has OM1 raised over time?
OM1 has raised $176M.
-
Who are OM1’s investors?
7wire Ventures, Breyer Capital, D1 Capital Partners, Kaiser Permanente, and Koa Labs are 5 of 10 investors who have invested in OM1.
-
Who are OM1’s competitors?
MedeAnalytics, Innovaccer, FIGmd, NantHealth, and Clinical Ink are some of the 17 competitors of OM1.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process